ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1502 • 2015 ACR/ARHP Annual Meeting

    Initiating Statin Medication and Risk of Fatigue in Rheumatoid Arthritis

    James S. Andrews1, Harlan Sayles2, Kaleb Michaud3 and Patricia P. Katz4, 1Rheumatology, University of California San Francisco, San Francisco, CA, 2University of Nebraska Medical Center, Omaha, NE, 3Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 4Rheumatology, UCSF, SF, CA

    Background/Purpose: Fatigue is common in Rheumatoid Arthritis (RA) and has a major impact on quality of life. Individuals with RA are also at increased risk…
  • Abstract Number: 2272 • 2015 ACR/ARHP Annual Meeting

    Physical Performance Contributes Only Marginally in Explaining Fatigue Variation in Persons with RA Moderately Affected By Their Disease

    Ingrid Demmelmaier1, Susanne Pettersson1, Birgitta Nordgren1, Alyssa B. Dufour1,2 and Christina H. Opava1, 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, 2Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA

    Background/Purpose: Fatigue is a prominent problem in persons with rheumatoid arthritis (RA) and often has a detrimental effect on quality of life. Besides variables directly…
  • Abstract Number: 2281 • 2015 ACR/ARHP Annual Meeting

    The Prediction of Fatigue in Early Rheumatoid Arthritis Patients

    Margot Walter1, T. Martijn Kuijper2, Mieke Hazes2,3, A.E.a.M. Weel4 and J.J. Luime5, 1Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Department of Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 5Department of Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands

    The prediction of fatigue in early Rheumatoid arthritis patientsBackground/Purpose: Rheumatoid arthritis-related fatigue is a common problem with a high impact on patients. How fatigue develops…
  • Abstract Number: 2335 • 2015 ACR/ARHP Annual Meeting

    How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)

    Isabel Castrejón1, Elena Nikiphorou2, Ruchi Jain1, Annie Huang1, Joel A. Block3 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Addenbrooke's Hospital, Cambridge, United Kingdom, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Fatigue is an important problem for many patients with rheumatic diseases. Fatigue is associated with disease severity, psychological distress, and a poorer quality of…
  • Abstract Number: 2337 • 2015 ACR/ARHP Annual Meeting

    Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards

    Vitalie Nizeica1, Myriam Normand2, Delphine Denarie1, Béatrice Pallot Prades1, Philippe Collet1, Adamah Amouzougan1, Hervé Locrelle1,2, Thierry Thomas1,2 and Hubert Marotte1,2, 1Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France, 2INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France

    Background/Purpose: In rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) patients, fatigue has been mainly related to disease activity. Current management of rheumatic inflammatory diseases aims…
  • Abstract Number: 2637 • 2015 ACR/ARHP Annual Meeting

    Prevalence of Unacceptable Pain and the Risk of Fatigue and Sleeping Problems in Early Rheumatoid Arthritis Patients

    Joakim Lindqvist1, Maria Sandberg2,3, Saedis Saevarsdottir4, Reem Altawil4, Lars Klareskog5, Lars Alfredsson6 and Jon Lampa7, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 2Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden, 3The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 6Unit of Cardiovascular Epidemiology, Institute of Enviornmental Medicine, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden, 7Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Pain is a commonly reported cause of affliction in RA-patients, also after adequate anti-rheumatic treatment. The objective of this study was to investigate the…
  • Abstract Number: 2638 • 2015 ACR/ARHP Annual Meeting

    Multiple Psychosocial Factors Influence Subjective Assessments of Disease Activity in Rheumatoid Arthritis

    Ying L. Liu1, Joan M. Bathon2,3 and Jon T. Giles4, 1Internal Medicine, Columbia University Medical Center, New York, NY, 2Medicine, Columbia University, College, New York, NY, 3Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 4Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY

    Background/Purpose: Measuring disease activity in rheumatoid arthritis (RA) is important in evaluating efficacy of treatments, but many tests are subjective and lead to discordance in…
  • Abstract Number: 2681 • 2015 ACR/ARHP Annual Meeting

    Physical Function, Sleep, Depression but Not CRP Level Is Associated with Fatigue in Patients with Established Rheumatoid Arthritis

    Yong Gil Hwang1, Juan (June) Feng2, Heather Eng2, Jason Lyons2, Anthony Fabio3 and Larry W. Moreland4, 1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 3Department Of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by inflammation of the joints and fatigue. Although many studies have identified risk factors for RA-associated fatigue, few studies…
  • Abstract Number: 2883 • 2015 ACR/ARHP Annual Meeting

    Relationship Between Improvements in Fatigue and Signs & Symptoms of Active Psoriatic: Arthritis a Sub-Analysis of a Phase 3 Study with Secukinumab

    Laure Gossec1, Tore K. Kvien2, Philip G. Conaghan3, Mikkel Østergaard4, Juan D. Cañete5, C. Gaillez6, Shephard Mpofu6, Bintu Sherif7 and Steffen Jugl8, 1Rheumatology Department, Paris 06 University,Hôpital Pitié Salpêtrière, Paris, France, 2Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 4Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 5Rheumatology, Hospital Clinic and IDIBAPS, Barcelona, Spain, 6Novartis Pharma AG, Basel, Switzerland, 7RTI Health Solutions, Durham, NC, 8BF I&D GPA, Health Economics and Outcomes Research, Novartis Pharma AG, Basel, Switzerland

    Background/Purpose:  Fatigue is highly important to patients (pts) with psoriatic arthritis (PsA). Secukinumab, an anti-interleukin-17A monoclonal antibody, significantly improved the signs and symptoms of active…
  • Abstract Number: 3243 • 2015 ACR/ARHP Annual Meeting

    A Randomized Controlled Trial for a Physical Activity Intervention for RA Fatigue

    Patricia P. Katz1, Mary Margaretten2, Steven Gregorich1, Sandi Kaplan3, Stephanie Rush4 and Laura Trupin1, 1Medicine, University of California San Francisco, San Francisco, CA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Arthritis Research Group, University of California, San Francisco, CA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Fatigue is a major problem for people with RA.  Physical inactivity is an indirect risk factor for fatigue1. We tested the effect of a…
  • Abstract Number: 288 • 2014 ACR/ARHP Annual Meeting

    Establishing Clinical Meaning and Defining Important Differences in Patient Reported Outcome Measures of Physical Function, Fatigue and Pain Interference in Juvenile Idiopathic Arthritis

    Esi M. Morgan DeWitt1, Bin Huang2,3, Kimberly Barnett4, Adam Carle5, Constance Mara6 and Karon Cook7, 1Department of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 3Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, 4Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Center for Patient-Centered Outcomes - Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose Patient reported outcome measures (PROs) are used increasingly in clinical care. A framework to interpret scores according to degree of clinical severity would enhance…
  • Abstract Number: 2397 • 2014 ACR/ARHP Annual Meeting

    Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with  Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study

    Marlène Genty1, Marie Kostine2, Elodie Ardouin3, Bernard Combe4 and Cédric Lukas5, 1RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, 2Rheumatology, CHU Pellegrin, Bordeaux, France, 3Rheumatology, Limoges University Hospital, Limoges, France, 4Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 5Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France

    Background/Purpose The functional burden of disease in Rheumatoid arthritis (RA) patients, mainly caused by inflamed joints, is often worsened by extra-articular manifestations, among which asthenia remains…
  • Abstract Number: 2330 • 2014 ACR/ARHP Annual Meeting

    Construct Validity of the Adult Myopathy Assessment Tool in Individuals with Inclusion Body Myositis

    Michael Harris-Love1, Galen Joe2, Todd Davenport3, Joseph Shrader2, Beverly McElroy4, Goran Rakocevic5, Olavo Vasconcelos6 and Marinos Dalakas5, 1Geriatrics Service, VA Medical Ctr, Washington, DC, 2Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD, 3Department of Physical Therapy, University of the Pacific, Stockton, CA, 4National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 5Department of Neurology, Thomas Jefferson University, Philadelphia, PA, 6Department of Neurology, Richmond Veterans Affairs Medical Center, Richmond, VA

    Background/Purpose The Adult Myopathy Assessment Tool (AMAT) is a 13-item performance-based battery developed to assess function and anaerobic endurance in adults with muscle disease.  The…
  • Abstract Number: 2227 • 2014 ACR/ARHP Annual Meeting

    Physical Impairment in Patients with Idiopathic Inflammatory Myopathies Is Predicted By the American College of Rheumatology Functional Status Measure

    Laura Cleary1, Leslie J. Crofford2, Archana Srinivas1, Heather Bush1, Catherine Starnes1, Qian Fan1, Jidan Duan1, Kirk Jenkins1, Natasha Fraser1, Matthew Rutledge1 and Beatriz Hanaoka3, 1University of Kentucky, Lexington, KY, 2Div of Rheumatology & Immunology, Vanderbilt University, Nashville, TN, 3Rheumatology, University of Kentucky, Lexington, KY

    Background/Purpose  The American College of Rheumatology classification criteria of functional status (ACR-FS) in Rheumatoid Arthritis is used as a measure of the consequences of impairment…
  • Abstract Number: 2081 • 2014 ACR/ARHP Annual Meeting

    Ehlers-Danlos Hypermobile (EDS-HT) Patients and Postural Instability : Another Clue to Explain Pain and Fatigue ?

    Roland Jaussaud1, Elodie Vlamynck2, Rami Haidar3, Dorothée Lambert4, Violaine Laurant-Noel5 and Amélie Servettaz5, 1Médecine interne, maladies infectieuses, immunologie clinique, CHU de Reims, REIMS, France, 2Cabinet d'Orthopédie, Versailles, France, 3Cabinet d'Orthopédie, Lille, France, 4Médecine interne, maladies infectieuses, Immunologie clinique, CHU Reims, Reims, France, 5Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré. CHU de Reims, Reims, France

    Background/Purpose Postural instability was found in several functional disorders including dyslexia, chronic pain and fibromyalgia. Furthermore, the link between vertical heterophoria (VH) and postural control…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology